August 4, 2022
Amgen plans to acquire a fellow Californian biotechnology company, ChemoCentryx, for $3.7 billion in a deal meant to deepen its pool of medicines targeting inflammation and the kidneys. The companies expect their deal, announced Thursday, to close sometime between October […]
July 26, 2022
Upon closing of the transaction, a newly formed holding company, NewAmsterdam Pharma Company NV, will be led by Michael Davidson, chief executive officer of the company. The Dutch biotech will receive approximately $235m from a private placement led by Frazier […]
July 21, 2022
Maggie Carmichael wasn’t developing like other kids. As a toddler, she wasn’t walking and had a limited vocabulary for her age. She was diagnosed with PMM2-CDG, potentially fatal gene mutations that cause abnormal enzyme activity — and affect fewer than […]
Clinical Trials, Research and Development
August 1, 2022
Biopharma DiveConcert Pharmaceuticals, a small biotechnology company based in Lexington, Massachusetts, plans to seek Food and Drug Administration approval for its experimental hair loss drug after reporting success in the second of two late-stage clinical trials. As in the first study, […]
Cell and Gene Therapy, Industry, News
August 1, 2022
PharmaphorumThe US biotech – which already has three antisense drugs for DMD on the market – had said earlier it was planning to delay the application into 2023, so the new announcement marks an acceleration of its plans. Sarepta reported […]
July 27, 2022
PharmaphorumThe vaccine, codenamed BNT162b5, codes for “enhanced” prefusion spike proteins from the original wild-type strain of the virus and the Omicron variant that are designed to increase “the magnitude and breadth of the immune response.” The phase 2 trial will […]
July 27, 2022
PMLiVEThe National Institute of Allergy and Infectious Diseases (NIAID) director specifically detailed the call for pan-coronavirus candidates and mucosal options that can be given to patients intranasally, all the while reinforcing that “innovative approaches are clearly needed to induce broad […]